KFDA mulls leniency on 120 pharmaceutical firms

The Korea Food and Drug Administration is unlikely to filed a complaint against 120 drugmakers who produced 122 drugs and medical goods confirmed to have used talc contaminated with asbestos last April.

In a briefing session with medical production managers on June 3, the KFDA officer Yoo Moo-young said that the administration seeks to mete out more alleviated administration disposition on t...